Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;16(6):1729-1731.
doi: 10.1007/s11739-021-02633-y. Epub 2021 Jan 19.

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder

Stefano Tamburin  1 , Elisa Mantovani  2 , Ernesto De Bernardis  3 , Donato Zipeto  2 , Fabio Lugoboni  4 ; Gruppo InterSERT di Collaborazione Scientifica (GICS)
Collaborators, Affiliations
Comment

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder

Stefano Tamburin et al. Intern Emerg Med. 2021 Sep.
No abstract available

Keywords: Alcohol related liver disease; Alcohol use disorder; COVID-19; Disulfiram; SARS-CoV-2; Treatment.

PubMed Disclaimer

Conflict of interest statement

No conflict declared.

Comment on

  • A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. Boulware DR, et al. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492293 Free PMC article. Clinical Trial.

References

    1. Lin MH, Moses DC, Hsieh CH, Cheng SC, Chen YH, Sun CY, Chou CY. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antiviral Res. 2018;150:155–163. doi: 10.1016/j.antiviral.2017.12.015. - DOI - PMC - PubMed
    1. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discov. 2020;19:149–150. doi: 10.1038/d41573-020-00016-0. - DOI - PubMed
    1. Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;3836:517–525. doi: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed
    1. Italian Government Civil Protection Department. http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bc.... Accessed 18 Jun 2020
    1. Vollmer MAC, Mishra S, Unwin HJT, Gandy A, Mellan TA, Bradley V et al. (2020) Imperial College COVID-19 Response Team. Report 20: Using mobility to estimate the transmission intensity of COVID-19 in Italy: A subnational analysis with future scenarios. https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020.... Accessed 26 Oct 2020